Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Diazepam Nasal Spray in Cluster Seizures
NCT02316847Phase 2Terminated
- Sponsor
- Acorda Therapeutics
- Start
- Dec 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diazepam nasal spray in seizure cluster, sponsored by Acorda Therapeutics. Started Dec 2014; status: terminated.
02
Drugs
diazepam nasal spray
03
Conditions
seizure cluster
Beyond the preview
Go deeper on NCT02316847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02316847.